|
Name/Symbol
|
Strain Name
|
Transgene/
Promoter and Regulatory Elements
|
Genetic Background
|
Behavioral
Phenotype
|
Neurological
Characteristics
|
Patents/
Availability
|
Primary Citation
|
|
APPSwDI/NOS2-/-
Symbol: APP/Nos ko
Updated 5/18/09
|
B6.Cg-Nos2tm1Lau Tg(Thy1-APPSwDutIowa)BWevn/J
|
Homozygous Tg(Thy1-APPSwDutIowa)BWevn females (Stock #007027) bred with heterozygous or homozygous Nos2tm1Lau
males (Stock #002609).
|
Donor strain: 129P2 via E14TG2a ES cell line. Background: C57BL/6.
|
Severe learning and memory deficits.
|
Mice progress from Aβ production and amyloid deposition to hyperphosphorylated
normal mouse tau, aggregation and redistribution of tau to somatodendritic regions
of neurons, significant neuronal loss (including loss of interneurons), moderate-severe
cerebral amyloid angiopathy.
|
The Jackson Lab,
under development, stock #009126. For research or non-commercial use only.
|
Colton et al., 2008
|
|
APPSwe (line C3-3)/PS1deltaE9 (line S-9)
Symbol: APP/PS1dE9
Posted 12/29/08
|
B6.Cg-Tg(APP695)3Dbo Tg(PSEN1dE9)S9Dbo/J
|
APPSwe (line
C3-3) crossed with PS1deltaE9 (line S-9).
|
Origin: (C57BL/6J x C3H/HeJ)F2, Congenic, Generation: [N7p]+N4F3 (19-Dec-08).
|
Double tg mice are viable and fertile.
|
Amyloid plaque deposition at 6 months. At 18 months, amyloid deposits increased
with significant but mild decreases in cholinergic markers (cortex and hippocampus)
and somatostatin levels (cortex). Older double tg mice impaired in all cognitive
tasks, and deficits in episodic-like memory tasks correlate with total amyloid-beta
peptide loads in the brain.
|
The Jackson Lab,
available, stock #005866. For research or non-commercial use only.
|
Savonenko et al., 2005
|
|
rTg(tauP301L) 4510
Symbol: Tau
Posted 12/10/05
|
|
Mice expressing activator transgenes tet-off ORF downsteam of Ca2+ calmodulin kinase
II promoter/Mice expressing responder transgene, TRE upstream of 4R0N tauP301L mutation.
|
Origin: Activator transgene mice on 129S6, backcross 5x. Responder transgene mice
(Tau P301L) on FVB/N.
|
Spatial defects, cognitive impairments early. At 9.5 months exhibit decreased ambulation,
body wt, hunched posture but continue to live, now >20 months.
|
Progressive age-related NFTs, and neuronal loss and severe forebrain atrophy. Tau
mRNA restricted to forebrain (neuronal cell types). With doxycycline treatment,
memory function recovered, neuron numbers stabilized, but NFTs continued to accumulate.
|
Contact Dr. Susan Stoddard
Mayo Medical Ventures, Rochester, MN
|
SantaCruz et al., 2005
|
|
Tet/GSK3β/Tauvlw
Symbol: GSK3β/Tau
Posted 10/30/2005
|
|
Crossed Tet/GSK3β
with Tauvlw/CamKIIa
and Thy1.2
|
Origin: C57Bl6j x CBA
|
Mice are viable and fertile
|
Mice show tau hyperphosphorylation in hippocampal neurons, with thioflavin-S staining
and formation of >10nm filaments. Atrophy seen in Tet/GSK-3β mice develops
faster in these Tet/ GSK-3β/Tauvlw mice.
|
European Patent Application No 01936609.5. Title, Model for neurodegenerative disease;
Inventors: JJ Lucas, F Hernandez, J Avila; Contact
Jesús Avila
or Felix Hernandez
|
Engel et al., 2005
|
|
Tet/GSK3β
Symbol: GSK3β
Posted 10/30/2005
|
|
Tet/GSK-3ß mice were generated by crossing mice expressing tTA under control of
the CamKIIa promoter (tTA) with mice that have incorporated the BitetO construct
in their genome (TetO). The double transgenic progeny (Tet/GSK-3ß) express GSK-3β
constitutively in the brain.
|
Origin: CBAxC57BL/6
|
Mice are viable and fertile
|
Overexpression of GSK-3β results in neurodegeneration such as β-catenin
destabilization and pretangle-like somatodendritic localization of hyperphosphorylated
tau. Highest level of transgenic GSK-3β expression is in the hippocampus, then
cortex.
|
European Patent Application No 01936609.5. Title, Model for neurodegenerative disease;
Inventors: JJ Lucas, F Hernandez, J Avila; Contact
Jesús Avila
|
Lucas et al., 2001
|
|
APPswe/Tauvlw
Symbol: APP/Tau
Posted 10/30/2005
|
|
Crossed APPSwe (Tg2576)
and Tauvlw
|
Origin: C57Bl6j x CBA x SJL
|
At 16 months single APPSwe and double tg mice have increased spatial memory impairment
compared to single Tauvlw
|
Double tg mice showed enhanced amyloid deposition accompanied by neurofibrillary
degeneration and overt neuronal loss in selectively vulnerable brain areas.
|
European Patent Application No 01936609.5. Title, Model for neurodegenerative disease;
Inventors: JJ Lucas, F Hernandez, J Avila; Contact
Jesús Avila
|
Perez et al., 2005
|
|
GSK3βS9A/Tau4R
Symbol: GSK3βS9A/Tau
Posted 8/27/2005
|
|
Crossed GSK3βS9A
with Tau4R
|
Origin: FVB/N (Crl)
|
|
Expression in neurons, high level in cortex and hippocampus. Hyperphosphorylation
of tau at 4-6 weeks, no insoluble tau aggregates or tangles. Rescue of tau axonopathy
of tau 4R.
|
Contact Paul Van Dun
|
Spittaels et al., 2000
|
|
APPLo/PS1A246E
Symbol: APP/PS1
Posted 7/26/2005
|
|
Crossed APPV717I (London)
with PS1A246E
|
Origin: FVB/N (Crl)
|
|
Both transgenes co-expressed in neurons only. Mice at 6-9 months have increased
Aβ levels with amyloid plaques and CAA.
|
Contact Paul Van Dun
|
Dewachter et al., 2000
|
|
APPLo/PS1(n-/-)
Symbol: APP/PS1
Posted 7/26/2005
|
|
Crossed APP(London)
with PS1 (n-/-).
|
Origin: FVB/N (Crl)
|
|
In bigenic mice the neuronal absence of PS1 effectively prevented amyloid pathology,
even in mice that were 18 months old. LTP also was rescued in bigenic mice but not
the cognitive defect of APP(V717I) mice.
|
Contact Paul Van Dun
|
Dewachter et al., 2002
|
|
BACE x APP(V717I)
Symbol: BACE/APP
Posted 6/10/2005
|
|
Crossed BACE-1 (Line 16) (Willem) with
APP(V717I)/mutation
hBACE and APP London/mouse Thy 1
|
Origin: Offspring are double tg that are heterozygous for both transgenes and with
identical FVB/C57BL background.
|
|
Amyloidogenic processing is increased at Asp1 and Glu11 resulting in more Aβ
peptides in bigenic brains. In older bigenic mice BACE1 increased the number of
diffuse and senile amyloid plaques. Vascular amyloid deposition was reduced compared
single APPV717I mice.
|
Contact Paul Van Dun
|
Willem et al., 2004
|
|
APP/ADAM10 OE
Symbol: APP/ADAM
Posted 6/10/2005
|
|
APPV717I were
intercrossed with ADAM10
|
Origin: FVB/N
|
Improved Morris Water Maze test compared to APPV717I mice.
|
Bigenic mice showed increased secretion of the neurotrophic soluble α-secretase-released
N-terminal APP domain (APPsα), reduced formation of Aβ peptides, and prevented
their deposition in plaques. Functionally, impaired long-term potentiation and cognitive
deficits were alleviated.
|
Not available.
Contact Falk Fahrenholz
Fax 49-6131-392-5348
|
Postina et al., 2004
|
|
APP/ADAM10 dn (catalytically inactive
mutant)
Symbol: APP/ADAM
Posted 6/10/2005
|
|
APPV717I were
intercrossed with ADAM10 dn
|
Origin: FVB/N
|
Improved Morris Water Maze test compared to APPV717I mice.
|
Expression of ADAM10dn led to an enhancement of the number and size of amyloid plaques
in the brains of double-transgenic mice.
|
Not available.
Contact Falk Fahrenholz
Fax 49-6131-392-5348
|
Postina et al., 2004
|
|
PS2N141I/APPSwe
Symbol: PS2-APP
Posted 6/9/2005
|
|
Crossed male APPSwe (AD147.71H)
with female PS2N141I
(Prp-huPS2.30H). Murine prion protein genomic fragment (pPrnpHG) was used for PS2
and mThy-1.2 for APPSwe
|
Origin: C57BL/6 x DBA/2.
|
Behavioral changes begin when Aβ deposits and inflammation appear in the subiculum
and frontolateral cortex.
|
At 8 months, age-related cognitive deficits and amyloid deposits with inflammation
in neo-and limbic cortices. Metabolic profile at 20 months indicates hypometabolism.
|
Contact: Laurence Ozmen
Laurence.ozmen@roche.com
|
Richards et al., 2003
|
|
APP/RAGE
Symbol: RAGE
Posted 4/1/2005
|
|
hRAGE (see Yan wt hRAGE)
crossed with mAPPSwInd (see TJL #004661)
|
C57BL/6J, generation >N10
|
|
Earlier abnormalities in spatial learning/memory, accompanied by altered activation
of markers of synaptic plasticity and exaggerated neuropathologic findings than
in single tg mice.
|
Contact: Shi Du Yan,
sdy1@columbia.edu
|
Arancio et al., 2004
|
|
APP/DN-RAGE
Symbol: RAGE
Posted 4/1/2005
|
|
Full-length dominate negative hRAGE /PDGF-ß promoter/6apc1 vector/microinjected
into B6CBAF1/J oocytes/ crossed with mAPP (see TJL #004661)
|
C57BL/6J, generation >N10
|
Normal reproduction and performance
|
Tg APP/dnRAGE animals displayed preservation of spatial learning/memory and diminished
neuropathologic changes.
|
Contact: Shi Du Yan,
sdy1@columbia.edu
|
Arancio et al., 2004
|
|
APPSw/hBACE
Symbol: APP/BACE
Posted 3/6/2005
|
|
Crossed APPSw(KM670/671NL)(Tac
#001349) and hBACE (Lee)
|
Bigenic mice C57BL/6/C3H/SJL
|
N/A
|
High BACE overexpression inhibited amyloid formation despite increased β-cleavage
of APP, and shifted the subcellular location of APP cleavage to the neuronal perikarya
early in the secretory pathway thereby depleting APP destined for axonal transport.
|
Contact: Virginia M-Y Lee
vmylee@mail.med.upenn.edu
|
Lee et al., 2005
|
|
APP751SL/PS1 KI
Symbol:APP/PS1
Updated 5/22/2005
|
|
PS1(M233T) (L235P) and APP751 London (V717I), Swedish (K670N/M671L)/Thy1
|
Origin: C57BL/6
|
Viable and fertile animals
|
Mice show acceleration of Aβ peptide deposition and develop age-dependent massive
neuronal loss in hippocampus (CA1/2 subfield). Strong Aβ immunostaining and
accumulation of thioflavine-S-positive stain in pyramidal cell layer precede neuronal
loss. Strong astrogliosis occurrs near Aβ-positive neurons.
|
Laurent Pradier
|
Casas et al., 2004
|
|
cPS1 conditional Double Ko (cDKo)
Symbol: PS1
Posted 7/10/04
|
|
Crossed floxed PS1
(fPS1), αCaMKII-Cre transgenic mice and
PS2-/- mice together to obtain fPS1/fPS1;αCaMKII-Cre;PS2-/-
mice.
|
Origin: C57BL6/129 hybrid
|
Viable, no difference from controls. No alterations in behavior, motor coordination
or exploratory anxiety.
|
Mice lacking both presenilins in forebrain exhibit impairments in memory and synaptic
plasticity. With age they develop neurodegeneration of cerebral cortex and worsening
memory and synaptic function with an increase in p25 and hyperphosphorylated tau.
|
Contact Jie Shen
jshen@rics.bwh.harvard.edu
|
Saura et al., 2004
|
MAPT Mapt GFP
(See JAX datasheet)
Updated 1/18/05
|
STOCK Mapttm1(GFP)Klt Tg(MAPT)8cPdav/J
|
Double mutant mice were generated by crossing hTau transgenic mice (mouse line 8C)
with Mapt targeted mutant mice (Mapt exon disrupted, replaced with EGFP fused to
the first 31 MAPT aa.
|
Targeted allele = J1 ES cell then C57BL/6 blastocysts, homozygous. Transgenic allele=
Swiss Webster/ B6D2F1, hemizygous
|
Mice are viable and fertile.
|
No endogenous mouse Tau, six isoforms of hTau expressed. Hyperphosphorylated tau
detected in cell bodies and dendrites. Paired helical filaments of aggregated insoluble
Tau isolated from brain at 2 months.
|
Available
The Jackson Lab: Stock #004808
|
Andorfer et al., 2003
|
|
PS-1(P264L)/APPswe
Symbol: PS-1/APP
Posted 1/23/04
|
|
PS-1 (P264L) mice cross-bred with APP695Swe (Tg2576) or APPsweKI
|
|
|
Cultured neurons have increased Aβ42 and reduced Aβ40. PS-1 mutation increases
Aβ42 levels and accelerates amyloid deposits and gliosis.
|
Contact Dorothy Flood at dflood@cephalon.com
or Steve Trusko strusko@cephalon.com at
Cephalon
|
Siman et al., 2000.
|
|
APPswe/PS1(A246E)
Symbol: APP695; Psen1
(See JAX datasheet)
Updated 12/29/08
|
B6C3-Tg(APP695)3Dbo Tg(PSEN1)5Dbo/J
|
Psen-1 tg: hPsen-1 (A246E substitution) (line N-5)/Prnp/B6C3H pronuclei. APP tg:
StrainC3B6-Tg(APP695)3Dbo (founder line C3-3) (TJL 003375). Psen-1(A246E) crossed with APPSwe = double
trangenic
|
Origin:B6;C3H. Mated double transgenics to C3B6F1 mice. Mice are hemizygous (only
1 in 4 pups is a double transgenic). Generation: F2N2+N1p.
|
|
Elevated levels of the Aβ1-42(43) peptide detected in mouse brain homogenates.
By 9 months of age, numerous amyloid deposits detected and they increase dramatically
between the ages of 10 and 12 months.
|
Available
The Jackson Lab,
cryopreserved, stock #003378. For research or non-commercial use only.
|
Borchelt et al, 1997
|
|
Mo/Hu APPswe PS1dE9
Symbol: APP695; PSEN1;
(See JAX datasheet)
Updated 12/11/08
|
B6C3-Tg(APPswe, PSEN1dE9)85Dbo/J
|
B6C3HF2 pronuclei coinjected with hPsen-1 and APP695/MoPrnp
|
B6C3F1/J background. Cross tg +/+ sibling to Hemizygote. BackcrossG1. Generation:
N1F10 (20-DEC-06).
|
Exhibit selective spatial deficit in Morris WM and disinhibitory tendencies in elevated
plus maze (Lalond et al., Neurosci Lett 2005)
|
Develop β-amyloid deposits in the brains of transgenic animals by 6 to 7 months
of age. APP and PSEN1 are immunodetected in whole brain protein homogenates.
|
The Jackson Lab, currently on
HOLD, Stock 004462. For research or non-commercial use only.
|
Jankowsky et al, 2001
|
|
Mo/Hu APPswe PS1dE9
Symbol: APP695; PSEN1;
(See JAX datasheet)
Posted 12/11/08
|
B6Cg-Tg(APPswe, PSEN1dE9)85Dbo/J
|
B6C3HF2 pronuclei coinjected with hPsen-1 and huAPP695/MoPrnp
|
Origin: (C57BL/6 x C3H)F2, Backcrossed to C57BL/6J, Congenic, Generation: N8?+N3
(20-DEC-07).
|
Exhibit selective spatial deficit in Morris WM and disinhibitory tendencies in elevated
plus maze (Lalond et al., Neurosci Lett 2005)
|
Develop β-amyloid deposits in the brains of transgenic animals by 6 to 7 months
of age. APP and PSEN1 are immunodetected in whole brain protein homogenates.
|
The Jackson Lab,
available, stock # 005864. For research or non-commercial use only.
|
Jankowsky et al., 2001
|
|
3-Repeat Tau + PSI M146L
|
|
Tg expressing 3-repeat human tau isoform, without the N-terminal insert, under the
control of a modified promoter of the 3-hydroxy-methyl-glutaryl coenzyme. PS1Tg
generated using human mutated PS1M146L under the control of the same promoter. Doubly
transgenic mice for human tau and human mutated PS1M146L were generated by cross-breeding
of single transgenic mice.
|
|
|
Increased expression of the PS1 holoprotein was observed. Proteolytic fragments
of PS1 did not appear to be modified. A somatodendritic accumulation of the transgenic
tau and an increase in tau phosphorylation in both tau- and tau/PS1 Tgs. Neurofibrillary
tangles were not observed in animals analyzed up to 17 months.
|
Contact J.P. Brion
jpbrion@ulb.ac.be
|
Boutajangout et al. Neuroscience Letters 318 (2002) 29–33
|
|
APPSwe 2576/Tau JNPL3
Symbol: APP/Tau
Updated 11/1/10
|
STOCK Tg(APPSWE)2576Kha Tg(Prnp-MAPT*P301L)JNPL3Hlmc
|
P301L 4 repeat Tau (JNPL3) x Appswe (Tg2576)
|
Origin: Crossed homozygous female Tau (Tac #2508M) with hemizygous male APP2576
(Tac #1349T).
|
Developed motor disturbances similar to JNPL3, with identical range in age of onset,
including progressive hindlimb weakness, hunched posture, eye irritations, reduced
vocalization, and decreased grooming.
|
Developed Aβ deposits at the same age as Tg2576; exhibited neurofibrillary
tangle pathology that was substantially enhanced in the limbic system and olfactory
cortex.
|
Available: Model
#002469.
Control Model
#003273 For research purposes only. For breeding must have a Research Crossbreeding
Agreement with Taconic. No distribution to third parties.
|
Lewis et al., 2001.
|
|
APPV717/ ApoE-/-
|
|
|
(Swiss Webster X C57BL/6 X DBA/2) X C57BL/6
|
|
fibrillar Ab deposits and neuritic plaques by 15 months of age and substantially
(>10-fold) more fibrillar deposits were observed in apoE4-expressing APPV717F TG
mice.
|
|
Holtzman
|
|
APP + Alpha Synuclein
|
|
Heterozygous hSYN mice from line D were crossed with heterozygous hAPP mice from
line J9
|
|
|
|
|
Masliah et al, 2001
|